Genome wide exome sequencing showed that between 50–70% of fibroids, depending on patient ethnicity and fibroid number, contained mutations primarily in the second exon of the Mediator Complex subunit 12 (MED12) gene [7]. This evidence concerns the gene MED12 and leiomyoma.